Annual CFO
-$8.45 M
+$850.80 K+9.15%
December 31, 2023
Summary
- As of February 7, 2025, HOTH annual cash flow from operations is -$8.45 million, with the most recent change of +$850.80 thousand (+9.15%) on December 31, 2023.
- During the last 3 years, HOTH annual CFO has fallen by -$2.31 million (-37.73%).
- HOTH annual CFO is now -301.75% below its all-time high of -$2.10 million, reached on December 31, 2018.
Performance
HOTH Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$1.63 M
-$42.90 K-2.70%
September 30, 2024
Summary
- As of February 7, 2025, HOTH quarterly cash flow from operations is -$1.63 million, with the most recent change of -$42.90 thousand (-2.70%) on September 30, 2024.
- Over the past year, HOTH quarterly CFO has dropped by -$42.90 thousand (-2.70%).
- HOTH quarterly CFO is now -363.45% below its all-time high of -$352.70 thousand, reached on March 31, 2018.
Performance
HOTH Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$8.02 M
+$2000.00+0.02%
September 30, 2024
Summary
- As of February 7, 2025, HOTH TTM cash flow from operations is -$8.02 million, with the most recent change of +$2000.00 (+0.02%) on September 30, 2024.
- Over the past year, HOTH TTM CFO has increased by +$2000.00 (+0.02%).
- HOTH TTM CFO is now -2174.37% below its all-time high of -$352.70 thousand, reached on March 31, 2018.
Performance
HOTH TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
HOTH Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.2% | -2.7% | +0.0% |
| 3 y3 years | -37.7% | +39.5% | +9.3% |
| 5 y5 years | -301.8% | +0.2% | -62.1% |
HOTH Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.1% | -12.8% | +58.1% | -1.8% | +33.6% |
| 5 y | 5-year | -70.8% | +30.1% | -148.7% | +58.1% | -62.1% | +33.6% |
| alltime | all time | -301.8% | +30.1% | -363.4% | +58.1% | -2174.4% | +33.6% |
Hoth Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.63 M(+2.7%) | -$8.02 M(-0.0%) |
| Jun 2024 | - | -$1.59 M(-7.7%) | -$8.02 M(+1.8%) |
| Mar 2024 | - | -$1.72 M(-43.9%) | -$7.88 M(-6.7%) |
| Dec 2023 | -$8.45 M(-9.2%) | -$3.07 M(+87.7%) | -$8.45 M(+6.6%) |
| Sep 2023 | - | -$1.64 M(+12.9%) | -$7.93 M(-8.7%) |
| Jun 2023 | - | -$1.45 M(-36.7%) | -$8.68 M(-8.2%) |
| Mar 2023 | - | -$2.29 M(-10.2%) | -$9.45 M(+1.6%) |
| Dec 2022 | -$9.30 M(-23.1%) | -$2.55 M(+6.8%) | -$9.30 M(-12.7%) |
| Sep 2022 | - | -$2.39 M(+7.5%) | -$10.65 M(-2.9%) |
| Jun 2022 | - | -$2.22 M(+4.0%) | -$10.96 M(-4.7%) |
| Mar 2022 | - | -$2.14 M(-45.2%) | -$11.50 M(-4.8%) |
| Dec 2021 | -$12.09 M | -$3.90 M(+44.4%) | -$12.09 M(+36.7%) |
| Sep 2021 | - | -$2.70 M(-2.2%) | -$8.85 M(+15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$2.76 M(+1.5%) | -$7.64 M(+5.0%) |
| Mar 2021 | - | -$2.72 M(+314.2%) | -$7.27 M(+18.6%) |
| Dec 2020 | -$6.13 M(+24.0%) | -$657.30 K(-56.1%) | -$6.13 M(-12.1%) |
| Sep 2020 | - | -$1.50 M(-37.6%) | -$6.97 M(-2.0%) |
| Jun 2020 | - | -$2.40 M(+51.5%) | -$7.12 M(+23.4%) |
| Mar 2020 | - | -$1.58 M(+5.6%) | -$5.77 M(+16.6%) |
| Dec 2019 | -$4.95 M(+135.3%) | -$1.50 M(-8.5%) | -$4.95 M(+26.7%) |
| Sep 2019 | - | -$1.64 M(+56.5%) | -$3.90 M(+31.7%) |
| Jun 2019 | - | -$1.05 M(+37.0%) | -$2.96 M(+17.9%) |
| Mar 2019 | - | -$764.00 K(+67.9%) | -$2.51 M(+19.6%) |
| Dec 2018 | -$2.10 M | -$455.10 K(-34.8%) | -$2.10 M(+27.6%) |
| Sep 2018 | - | -$697.60 K(+16.8%) | -$1.65 M(+73.4%) |
| Jun 2018 | - | -$597.20 K(+69.3%) | -$949.90 K(+169.3%) |
| Mar 2018 | - | -$352.70 K | -$352.70 K |
FAQ
- What is Hoth Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Hoth Therapeutics?
- What is Hoth Therapeutics annual CFO year-on-year change?
- What is Hoth Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Hoth Therapeutics?
- What is Hoth Therapeutics quarterly CFO year-on-year change?
- What is Hoth Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Hoth Therapeutics?
- What is Hoth Therapeutics TTM CFO year-on-year change?
What is Hoth Therapeutics annual cash flow from operations?
The current annual CFO of HOTH is -$8.45 M
What is the all time high annual CFO for Hoth Therapeutics?
Hoth Therapeutics all-time high annual cash flow from operations is -$2.10 M
What is Hoth Therapeutics annual CFO year-on-year change?
Over the past year, HOTH annual cash flow from operations has changed by +$850.80 K (+9.15%)
What is Hoth Therapeutics quarterly cash flow from operations?
The current quarterly CFO of HOTH is -$1.63 M
What is the all time high quarterly CFO for Hoth Therapeutics?
Hoth Therapeutics all-time high quarterly cash flow from operations is -$352.70 K
What is Hoth Therapeutics quarterly CFO year-on-year change?
Over the past year, HOTH quarterly cash flow from operations has changed by -$42.90 K (-2.70%)
What is Hoth Therapeutics TTM cash flow from operations?
The current TTM CFO of HOTH is -$8.02 M
What is the all time high TTM CFO for Hoth Therapeutics?
Hoth Therapeutics all-time high TTM cash flow from operations is -$352.70 K
What is Hoth Therapeutics TTM CFO year-on-year change?
Over the past year, HOTH TTM cash flow from operations has changed by +$2000.00 (+0.02%)